title: New Zealand Society of Gastroenterology statement on the use of biological therapy in inflammatory bowel disease.
authors.affiliation: University of Otago, Dunedin School of Medicine, Dunedin. michael.schultz@otago.ac.nz
authors.forename: Michael
authors.initials: M
authors.lastname: Schultz
authors.forename: Richard
authors.initials: R
authors.lastname: Gearry
authors.forename: Russell
authors.initials: R
authors.lastname: Walmsley
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Day
authors.forename: Alan
authors.initials: A
authors.lastname: Fraser
authors.forename: John
authors.initials: J
authors.lastname: Wyeth
authors.forename: Murray
authors.initials: M
authors.lastname: Barclay
authors.forename: Geoff
authors.initials: G
authors.lastname: Clover
authors.forename: Cathryn
authors.initials: C
authors.lastname: Whiteside
mesh_terms: D005762:Gastroenterology / Q000379:methods*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D009520:New Zealand; D017410:Practice Guidelines as Topic; D012955:Societies, Medical
chemical_list: D007155:Immunologic Factors